Sputum Cysteinyl Leukotrienes Increase 24 Hours after Allergen Inhalation in Atopic Asthmatics
- 1 May 2000
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 161 (5) , 1553-1558
- https://doi.org/10.1164/ajrccm.161.5.9906068
Abstract
We have used the relatively noninvasive technique of induced sputum to measure allergen-induced changes in the concentration of eicosanoid mediators in bronchial secretions from atopic asthmatics. Sputum induction was performed before and 24 h after inhalational allergen challenge in 14 atopic asthmatics who developed a late asthmatic reaction (LAR). Differential cell counts were made on sputum cytospins and eicosanoid (cysteinyl leukotrienes [cys LTs], prostaglandin D(2) [PGD(2)], and PGE(2)) concentrations were measured in the sputum supernatants. The percentage of eosinophils at baseline correlated with the concentration of cys LTs (r = 0.84, p < 0.001) but not prostanoid mediators. Allergen challenge produced a significant increase in the concentration of sputum cys LTs from 3. 45 ng/ml sputum to 11.95 ng/ml (p = 0.002), which correlated with the increase in sputum eosinophils (r = 0.55, p < 0.05). There were no significant changes in PGD(2) or PGE(2) concentrations in sputum supernatants in response to challenge. Thus, the noninvasive technique of induced sputum has been used to demonstrate increased cys LTs, but not prostanoids associated with LAR after allergen challenge. The correlation between eosinophil numbers and cys LT concentrations at baseline values and 24 h after allergen challenge is consistent with these cells being a principal source of cys LTs within the airways at these time pointsKeywords
This publication has 29 references indexed in Scilit:
- Urinary excretion of inflammatory mediators during allergen‐induced early and late phase asthmatic reactionsClinical and Experimental Allergy, 1998
- Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.American Journal of Respiratory and Critical Care Medicine, 1997
- Analytical methods for the measurement of leukotrienes and other eicosanoids in biological samples from asthmatic subjectsJournal of Chromatography A, 1996
- The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivoJournal of Allergy and Clinical Immunology, 1995
- Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in AsthmaticsAmerican Review of Respiratory Disease, 1992
- Elevated Levels of Leukotriene C4in Bronchoalveolar Lavage Fluid from Atopic Asthmatics after Endobronchial Allergen ChallengeAmerican Review of Respiratory Disease, 1990
- Allergen-stimulated Release of Thromboxane A2and Leukotriene E4in Humans: Effect of IndomethacinAmerican Review of Respiratory Disease, 1990
- Characteristics of formation and further metabolism of leukotrienes in the chopped human lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Leukotrienes, LTC and LTB, in bronchoalveolar lavage in bronchial asthma and other respiratory diseasesJournal of Allergy and Clinical Immunology, 1989
- Leukocytes and Mediators in Bronchoalveolar Lavage during Allergen-induced Late-phase Asthmatic ReactionsAmerican Review of Respiratory Disease, 1989